4
Changes in Ownership
Tyra Biosciences, Inc. Filed Acc 0000899243-21-036426
Chief Executive Officer acquired 34,007 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Harris Todd Chief Executive Officer | 2021-09-17 | Conversion | +34,007 | 1,696,343 | D: show line 1 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Harris Todd Chief Executive Officer | 2021-09-17 | Conversion · Series A Preferred Stock | −13,093 | 0 | D: show line 2 in the form |
Loading xslF345X03/doc4.xml…